Dr. Stephen Smith of the Smith Center for Infectious Diseases has conducted his own observational study using the same drugs as Dr. Didler Raoult in France. It’s an intra-cohort comparison. He finds that the Hydroxychloroquine spells “the beginning of the end of the pandemic.”
He treats everyone with Hydroxychloroquine and Azithromycin and has for a while, but that is not all he has discovered. Specific co-morbidities play a large part in younger patients who are becoming seriously ill.
Dr. Smith has treated 74 Cov-19 patients with the drugs and only two showed heart changes and they have other drugs. Of that number, 21 were pre-diabetic, 34 were diabetic. Also, the average severely ill patient is obese or overweight.
The younger patients he has seen with severe COVID who are intubated are diabetic or pre-diabetic or have some other severe disease. In Seattle, 58% of their ICU code patients were diabetic and morbidly obese. Pre-diabetics are also at risk, especially with a high BMI. They didn’t have anyone under 70 who didn’t have a very high BMI or who is not diabetic or pre-diabetic, get seriously ill.
Watch:
You can comment on the article after the ads and subscribe to the Daily Newsletter here if you would like a quick view of the articles of the day and any late news:
